Inhibikase Therapeutics (IKT) Capital Leases (2022 - 2024)
Inhibikase Therapeutics (IKT) posted quarterly Capital Leases of $58330.0 for Q1 2024, down 67.25% year-over-year from $178110.0 in Q2 2023, and down 35.28% quarter-over-quarter from $90124.0 in Q4 2023.
Inhibikase Therapeutics (IKT) Capital Leases (2022 - 2024) Analysis & Trends
Inhibikase Therapeutics (IKT) has reported Capital Leases for 3 consecutive years, with $58330.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Capital Leases fell 67.25% year-over-year to $58330.0; the TTM figure through Mar 2024 stood at $58330.0 (down 67.25% YoY), while the FY2023 annual figure was $90124.0, down 56.13% from the prior year.
- Capital Leases fell to $58330.0 in Q1 2024 per IKT's latest filing, from $90124.0 in the prior quarter.
- Across five years, Capital Leases topped out at $232020.0 in Q3 2022 and bottomed at $58330.0 in Q1 2024.
- Historically, Capital Leases has averaged $147859.9 across 3 years, with a median of $149971.0 in 2023.
- Annual changes were most pronounced in 2023 — Capital Leases sank 47.84% — and 2024, when it sank 67.25%.
- Inhibikase Therapeutics' Capital Leases stood at $205451.0 in 2022, then plunged by 56.13% to $90124.0 in 2023, then slumped by 35.28% to $58330.0 in 2024.
- Business Quant data shows IKT's Capital Leases at $58330.0 in Q1 2024, $90124.0 in Q4 2023, and $121013.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Inhibikase Therapeutics | 420.72 Mn | 261.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 58,330.00 |
| Dec 31, 2023 | 90,124.00 |
| Sep 30, 2023 | 121,013.00 |
| Jun 30, 2023 | 149,971.00 |
| Mar 31, 2023 | 178,110.00 |
| Dec 31, 2022 | 205,451.00 |
| Sep 30, 2022 | 232,020.00 |